U.S. markets closed

Emergent BioSolutions Inc. (EBS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
96.71+0.74 (+0.77%)
At close: 4:00PM EDT

97.95 +1.24 (1.28%)
After hours: 5:44PM EDT

Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
1,259,300
1,106,000
782,400
560,873
488,782
Cost of Revenue
447,500
433,500
322,300
195,707
131,284
Gross Profit
811,800
672,500
460,100
365,166
357,498
Operating Expense
548,900
558,400
370,300
240,881
251,976
Operating Income
262,900
114,100
89,800
124,285
105,522
Net Non Operating Interest Income Expense
-34,400
-38,400
-9,900
-4,837
-6,564
Other Income Expense
-
1,700
1,600
-815
263
Pretax Income
229,800
77,400
81,500
118,633
99,221
Tax Provision
59,500
22,900
18,800
36,039
36,697
Net Income Common Stockholders
170,300
54,500
62,700
82,594
51,776
Average Dilution Earnings
-
-
0
3,287
4,036
Diluted NI Available to Com Stockholders
170,300
54,500
62,700
85,881
55,812
Basic EPS
-
0.0011
0.0013
0.002
0.0013
Diluted EPS
-
0.001
0.0012
0.0017
0.0011
Basic Average Shares
-
51,500
50,100
41,816
40,184
Diluted Average Shares
-
52,400
51,400
50,328
49,335
Total Operating Income as Reported
262,900
114,100
89,800
124,285
105,522
Total Expenses
996,400
991,900
692,600
436,588
383,260
Net Income from Continuing & Discontinued Operation
170,300
54,500
62,700
82,594
51,776
Normalized Income
170,300
54,500
62,700
82,594
62,524
Interest Income
-
-
-
1,753
1,053
Interest Expense
34,400
38,400
9,900
6,590
7,617
Net Interest Income
-34,400
-38,400
-9,900
-4,837
-6,564
EBIT
264,200
115,800
91,400
125,223
106,838
EBITDA
376,600
-
-
-
-
Reconciled Cost of Revenue
394,400
381,500
285,100
195,707
131,284
Reconciled Depreciation
112,400
110,700
62,200
42,572
38,229
Net Income from Continuing Operation Net Minority Interest
170,300
54,500
62,700
82,594
62,524
Normalized EBITDA
376,600
226,500
153,600
167,795
145,067
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0